Novanta (NOVT) Stock
Precision photonics and motion control supplier for manufacturers. Here's the price, business snapshot, and what's worth knowing about Novanta in September 2026.
Novanta Inc. supplies precision photonics, laser and motion‑control components and subsystems to medical, semiconductor and industrial equipment manufacturers. Investors should know it operates as a specialised components supplier rather than a direct device maker, generating revenue from product sales, aftermarket parts and engineering services. With a market capitalisation around $4.07 billion, Novanta's growth has historically combined organic development of higher‑margin modules and selective acquisitions that expand technology or end‑market reach. Strengths include deep engineering expertise, close customer relationships and exposure to long‑term trends such as precision medicine and advanced manufacturing; risks include customer concentration, cyclicality in capital‑equipment spending, supply‑chain pressures and technological obsolescence. Financial performance can vary with end‑market cycles and the integration of acquisitions. This information is general and educational only — not personalised advice. Consider your time horizon and tolerance for risk and consult a regulated financial adviser before making investment decisions.
Novanta (NOVT) Stock Forecast
Analyst price target, next 12 months
$186.50
+28.3% vs today's $145.31
Price range over the last 12 months
In the middle of its 12-month range
Analysts covering Novanta have a consensus 12-month target of $186.50, above the current price of $145.31.
Analyst targets are opinions, not guarantees. Capital at risk. Data as of 24 Sep 2026.
Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts strongly recommend buying Novanta's stock, expecting its price to rise significantly.
Financial Health
Novanta Inc. shows strong revenue and profitability, supported by solid cash flow and book value.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why You’ll Want to Watch This Stock
Precision tech demand
Novanta benefits from rising need for precise photonics and motion control in medical and semiconductor equipment — though end‑market cycles can affect near‑term results.
R&D and innovation
Engineering depth and product development help drive differentiation, but sustained investment is needed and competition can erode margins.
Diversified end‑markets
Exposure to medical, industrial and semiconductor customers spreads risk, yet concentration among large OEMs and capital‑equipment cyclicality remain considerations.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
